Ixabepilone: new perspectives for its use in breast cancer
Despite significant advances in recent years, the drug therapy for breast cancer (BC) is still based on chemotherapy. The introduction of new effective cytostatic agents with a favorable toxicity profile is likely to remain an urgent objective for modern pharmacology in oncology. Ixabepilone, first...
Shranjeno v:
| Principais autores: | , , |
|---|---|
| Format: | Artigo |
| Jezik: | Russo |
| Izdano: |
Remedium Group LLC
2018-11-01
|
| Serija: | Медицинский совет |
| Teme: | |
| Online dostop: | https://www.med-sovet.pro/jour/article/view/2748 |
| Oznake: |
Brez oznak, prvi označite!
|